review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Laufey T. Amundadottir | Q30093106 |
P2860 | cites work | Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus | Q21134596 |
Genome-wide association study of pancreatic cancer in Japanese population | Q21136247 | ||
Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family | Q21144736 | ||
Finding the missing heritability of complex diseases | Q22122198 | ||
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 | Q23924183 | ||
Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence | Q24311830 | ||
C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA | Q24313007 | ||
Structural basis for recruitment of BRCA2 by PALB2 | Q24315745 | ||
A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth | Q24318407 | ||
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner | Q24320153 | ||
Extension of life-span by introduction of telomerase into normal human cells | Q24336088 | ||
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young | Q57916579 | ||
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden) | Q57948729 | ||
Renal tubular cells cultured from genetically modified animals | Q73177058 | ||
Exonic duplication of the hepatocyte nuclear factor-1beta gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5 | Q80171612 | ||
PALB2 mutations in European familial pancreatic cancer families | Q84094246 | ||
ABO blood group and risk of colorectal cancer | Q34949621 | ||
Chromosome 8q24-Associated Cancers and MYC. | Q34972340 | ||
Sox9: a master regulator of the pancreatic program | Q34972366 | ||
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer | Q35056055 | ||
Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locus | Q35085806 | ||
Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. | Q35118758 | ||
LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function. | Q35193215 | ||
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study | Q35630278 | ||
The functional spectrum of low-frequency coding variation | Q35840674 | ||
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer | Q35904497 | ||
The 8q24 gene desert: an oasis of non-coding transcriptional activity. | Q35919877 | ||
Systemic cancer and the FAMMM syndrome | Q35982685 | ||
Genetic and clinical characteristics of maturity-onset diabetes of the young | Q36162489 | ||
The CDKN2A (p16) gene and human cancer. | Q36437816 | ||
The ATM-dependent DNA damage signaling pathway | Q36547714 | ||
A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival | Q36600132 | ||
Genetic susceptibility to pancreatic cancer | Q36603692 | ||
TP63 gene in stress response and carcinogenesis: a broader role than expected | Q36689506 | ||
Human pancreatic digestive enzymes | Q36700204 | ||
Novel role of the muskelin-RanBP9 complex as a nucleocytoplasmic mediator of cell morphology regulation | Q36843160 | ||
Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1 | Q24533305 | ||
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
A relationship between cancer of stomach and the ABO blood groups | Q24565002 | ||
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 | Q24597370 | ||
ABO blood group and incidence of epithelial ovarian cancer | Q24599521 | ||
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis | Q24609915 | ||
Mammalian Krüppel-Like Factors in Health and Diseases | Q24612560 | ||
New common variants affecting susceptibility to basal cell carcinoma | Q24615109 | ||
A map of human genome variation from population-scale sequencing | Q24617794 | ||
Control of pancreas and liver gene expression by HNF transcription factors | Q24618003 | ||
Biological, clinical and population relevance of 95 loci for blood lipids | Q24622541 | ||
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer | Q24626464 | ||
Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes | Q24635080 | ||
Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study | Q24644661 | ||
Lung cancer susceptibility locus at 5p15.33 | Q24649980 | ||
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma | Q24657797 | ||
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene | Q24658271 | ||
Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer | Q26825812 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Cancer statistics, 2015 | Q27860576 | ||
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal | Q28115513 | ||
Creation of human tumour cells with defined genetic elements | Q28141602 | ||
A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis | Q28143357 | ||
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis | Q28145585 | ||
Clinical and genetic characteristics of hereditary pancreatitis in Europe | Q28250117 | ||
Hepatocyte nuclear factor 1alpha and beta control terminal differentiation and cell fate commitment in the gut epithelium | Q28279620 | ||
p130Cas: a key signalling node in health and disease | Q28282363 | ||
Integrin signalling adaptors: not only figurants in the cancer story | Q28299126 | ||
Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters | Q28299313 | ||
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group | Q28307042 | ||
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk | Q28385765 | ||
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility | Q28386653 | ||
Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
Very high risk of cancer in familial Peutz-Jeghers syndrome | Q34512286 | ||
Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). | Q34583807 | ||
Pancreatic cancer and the FAMMM syndrome | Q34584733 | ||
Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. | Q34586212 | ||
Extra-intestinal manifestations of familial adenomatous polyposis | Q34593970 | ||
Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature | Q34603196 | ||
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection | Q34620078 | ||
Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance | Q34646423 | ||
European cancer mortality predictions for the year 2014. | Q34661464 | ||
ABO blood groups and risk of cancer: a systematic review and meta-analysis | Q34662761 | ||
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling | Q34694716 | ||
Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth. | Q34699663 | ||
High trans-ethnic replicability of GWAS results implies common causal variants. | Q34778535 | ||
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian | Q34945185 | ||
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia | Q28397565 | ||
The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element | Q28588078 | ||
Discovery and refinement of loci associated with lipid levels | Q28661470 | ||
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations | Q28943254 | ||
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 | Q28943270 | ||
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia | Q28943339 | ||
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 | Q28943480 | ||
Genome-wide association study of survival in patients with pancreatic adenocarcinoma | Q28943489 | ||
Genome-wide association study identifies three new melanoma susceptibility loci | Q29416994 | ||
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility | Q29417007 | ||
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer | Q29417028 | ||
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study | Q29417074 | ||
Genome-wide association study identifies five susceptibility loci for glioma | Q29614921 | ||
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types | Q29614935 | ||
Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes | Q30416868 | ||
Structure and function of ETAA16: a novel cell surface antigen in Ewing's tumours | Q33218440 | ||
Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. | Q33480141 | ||
CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells | Q33648848 | ||
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer | Q33783766 | ||
Risk of pancreatic cancer in families with Lynch syndrome | Q33880380 | ||
Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2 | Q34038331 | ||
p63 and p73, the ancestors of p53. | Q34080237 | ||
Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). | Q34080597 | ||
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium | Q34094983 | ||
Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type 2 diabetes in Japanese | Q34142684 | ||
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer | Q34241383 | ||
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer | Q34314018 | ||
LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis | Q34319158 | ||
The epidemiology of pancreatitis and pancreatic cancer | Q34341477 | ||
BRCA1 and BRCA2: 1994 and beyond | Q34345297 | ||
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis | Q34378109 | ||
Dax1 Up-Regulates Oct4 Expression in Mouse Embryonic Stem Cells via LRH-1 and SRA | Q34392546 | ||
Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium | Q34422433 | ||
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression | Q36856343 | ||
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | Q36897003 | ||
ATM mutations in patients with hereditary pancreatic cancer | Q36913473 | ||
Genetic risk factors for pancreatic disorders | Q36933359 | ||
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer | Q36956156 | ||
Transcription factors in pancreatic development. Animal models | Q36965587 | ||
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? | Q37001375 | ||
Risk of pancreatic cancer in breast cancer families from the breast cancer family registry | Q37085786 | ||
BRCA1 and BRCA2: different roles in a common pathway of genome protection | Q37149848 | ||
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband | Q37222641 | ||
Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases | Q37486142 | ||
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer | Q37557629 | ||
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations | Q37669153 | ||
History, genetics, and strategies for cancer prevention in Lynch syndrome | Q37716875 | ||
Transcriptional control of acinar development and homeostasis | Q37809241 | ||
Role of p63 in cancer development. | Q37868336 | ||
The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis | Q38002202 | ||
Familial pancreatic cancer--current knowledge | Q38016055 | ||
Targeting LKB1 signaling in cancer. | Q38071485 | ||
ABO blood group: old dogma, new perspectives | Q38104553 | ||
Novel mutations and a mutational hotspot in the MODY3 gene | Q38345643 | ||
Familial Adenomatous Polyposis (FAP)-A Case Study and Review of Literature | Q38466964 | ||
Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation | Q39156056 | ||
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Q39190004 | ||
The ABO and Lewis blood-group system. Immunochemistry, genetics and relation to human disease | Q39978997 | ||
Common variants in HNF-1 alpha and risk of type 2 diabetes | Q40280144 | ||
IPF1, a homeodomain-containing transactivator of the insulin gene | Q40874284 | ||
Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden | Q42690527 | ||
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium | Q43538243 | ||
A population-based description of familial clustering of pancreatic cancer | Q44928964 | ||
Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen | Q46911281 | ||
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) | Q48056898 | ||
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations | Q48746431 | ||
Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis. | Q51061806 | ||
SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. | Q53307573 | ||
Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families | Q56436681 | ||
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL | Q56437244 | ||
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies | Q57250703 | ||
Lack of Replication of Seven Pancreatic Cancer Susceptibility Loci Identified in Two Asian Populations | Q57610440 | ||
The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells | Q57783827 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pancreatic cancer | Q212961 |
pancreatic neoplasm | Q7130412 | ||
P304 | page(s) | 314-25 | |
P577 | publication date | 2016-01-28 | |
P1433 | published in | International Journal of Biological Sciences | Q6051326 |
P1476 | title | Pancreatic Cancer Genetics | |
P478 | volume | 12 |
Q42012788 | A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway |
Q98290405 | Associations of novel variants in PIK3C3, INSR and MAP3K4 of the ATM pathway genes with pancreatic cancer risk |
Q50027269 | Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. |
Q58751735 | Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations |
Q57643835 | Familial pancreatic cancer |
Q39077718 | Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression |
Q96683580 | Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer |
Q38654350 | Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews. |
Q64904655 | LINC00673 rs11655237 C>T Polymorphism Impacts Hepatoblastoma Susceptibility in Chinese Children. |
Q38728412 | Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling |
Q49335684 | MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. |
Q48207536 | Non-coding regulatory variations: the dark matter of pancreatic cancer genomics |
Q90710469 | Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease |
Q42570044 | Pancreatic Cancer: Current Progress and Future Challenges |
Q55279308 | Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies? |
Q28079318 | Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer |
Q47118943 | Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling. |
Q40083252 | Racial Disparity in Gastrointestinal Cancer Risk |
Q38661110 | The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes |
Q64946310 | Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. |
Q50001765 | Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas. |
Search more.